Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1477647659
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
333 Cottman Ave, Fox Chase Cancer Center
Philadelphia, PA, 19111
Phone (215) 728-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
325 services
Medicare patients, 2024
123
Average age 75
Drug cost, 2024
$2.8M
656 prescriptions
Company payments, 2025
$38K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth R Plimack was code 99215 (office e&m - established), 157 times for 75 patients. In total Elizabeth R Plimack billed 325 services in 7 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 157 | 75 | $107.56 | $17K |
| 99214 Office E&M - Established | Facility | 84 | 54 | $76.94 | $6,463 |
| 99214 Office E&M - Established | Office | 37 | 28 | $105.09 | $3,888 |
| 99205 Office E&M - New | Facility | 17 | 17 | $139.05 | $2,364 |
| 99204 Office E&M - New | Facility | 11 | 11 | $108.15 | $1,190 |
By year: 2022 $45K for 470 services; 2023 $30K for 327 services; 2024 $32K for 325 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth R Plimack prescribed most often to Medicare patients was Abiraterone Acetate, with 187 prescriptions and refills. In total Elizabeth R Plimack wrote 656 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 187 | 187 | 25 | $316K |
| Prednisone Generic | 147 | 172 | 28 | $730 |
| Xtandi Enzalutamide | 48 | 48 | Under 11 | $476K |
| Votrient Pazopanib Hcl | 38 | 38 | Under 11 | $211K |
| Orgovyx Relugolix | 29 | 29 | Under 11 | $71K |
| Lenvima Lenvatinib Mesylate | 23 | 23 | Under 11 | $842K |
| Inlyta Axitinib | 23 | 23 | Under 11 | $408K |
| Bicalutamide Generic | 20 | 20 | 11 | $191 |
| Ondansetron Hcl Generic | 19 | 19 | 18 | $179 |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $196 |
| Dexamethasone Generic | 13 | 13 | 11 | $145 |
| Erleada Apalutamide | 12 | 14 | Under 11 | $108K |
Brand drugs: 199 claims; generic drugs: 457 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth R Plimack $38K ($38K in general payments such as food, travel and fees) from 13 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $18K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $18K |
| Merck Sharp & Dohme LLC MRK | 4 | $6,072 |
| Urogen Pharma, Inc. URGN | 1 | $5,565 |
| Astellas Pharma US Inc 4503.T | 1 | $4,600 |
| Pfizer Inc. PFE | 3 | $1,910 |
| Daiichi Sankyo Inc. 4568.T | 1 | $1,688 |
| Genentech, Inc. ROG.SW | 1 | $81.56 |
| Astellas Pharma Europe Ltd 4503.T | 2 | $78.98 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $30.67 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.